Premier's ProvideGx Program to Supply Sodium Bicarbonate Injection to Providers
July 23, 2019
July 23, 2019
CHARLOTTE, North Carolina, July 23 -- Premier, a healthcare improvement company, issued the following news release:
Premier Inc. (NASDAQ: PINC), through its ProvideGx(TM) program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare providers, a drug that has been in shortage in the U.S. for nearly two years.
Sodium bicarbonate injection is most commonly used for urgent treatment of cardiac emergencies, such as cardiac arre . . .
Premier Inc. (NASDAQ: PINC), through its ProvideGx(TM) program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare providers, a drug that has been in shortage in the U.S. for nearly two years.
Sodium bicarbonate injection is most commonly used for urgent treatment of cardiac emergencies, such as cardiac arre . . .